Atlas of the evolution of psoriasis lesions under Remicade : A dynamic standardized photographic library of moderate to severe psoriasis subjects treated with infliximab
Phase of Trial: Phase IV
Latest Information Update: 01 Oct 2014
At a glance
- Drugs Infliximab (Primary)
- Indications Psoriasis
- Focus Therapeutic Use
- Acronyms PHODYPSO
- Sponsors Merck Sharp & Dohme; Schering-Plough
- 06 Sep 2013 Trial association changed from Schering-Plough to Merck & Co as reported by ClinicalTrials.gov.
- 28 Jan 2011 Actual end date (Sep 2010) added as reported by ClinicalTrials.gov.
- 28 Jan 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.